Takahide Nakazawa Selected Research

Takahide Nakazawa Research Topics

Disease

32	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 03/2005
10	Neoplasms (Cancer) 10/2020 - 03/2005
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2008
7	Infections 04/2019 - 01/2008
6	Fibrosis (Cirrhosis) 01/2020 - 12/2007
4	Hemorrhage 11/2020 - 12/2007
4	Chronic Hepatitis C 04/2018 - 06/2008
3	Hepatic Encephalopathy 01/2022 - 05/2019
3	Portal Hypertension 09/2020 - 12/2007
2	Thrombosis (Thrombus) 07/2022 - 05/2014
2	Esophageal and Gastric Varices (Esophageal Varices) 11/2020 - 05/2016
2	Brain Diseases (Brain Disorder) 01/2020 - 04/2018
2	Liver Diseases (Liver Disease) 11/2018 - 10/2017
2	Neoplasm Metastasis (Metastasis) 03/2015 - 01/2012
2	Thrombocytopenia (Thrombopenia) 03/2014 - 08/2009
2	Hepatitis B 03/2011 - 01/2008
1	Adenocarcinoma 12/2022
1	Wandering Spleen 07/2022
1	Sarcopenia 09/2021
1	Myocarditis (Carditis) 08/2021
1	Autoimmune Hepatitis 01/2021
1	Ulcer 11/2020
1	Gastroesophageal Reflux (GERD) 11/2020
1	Heartburn (Pyrosis) 11/2020
1	Body Weight (Weight, Body) 09/2020
1	End Stage Liver Disease 01/2020
1	Rupture 01/2020
1	Varicose Veins (Varicose Vein) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Diarrhea 01/2020
1	Ascites 01/2020
1	Vomiting 01/2020
1	Sepsis (Septicemia) 04/2019
1	Non-alcoholic Fatty Liver Disease 04/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2019
1	Hemolysis 04/2019
1	Virus Diseases (Viral Diseases) 03/2014
1	Retinal Vein Occlusion 09/2012
1	Retinal Artery Occlusion 09/2012

Drug/Important Bio-Agent (IBA)

11	Sorafenib (BAY 43-9006)FDA Link 09/2020 - 08/2010
8	lenvatinibIBA 12/2022 - 01/2020
4	InterferonsIBA 04/2018 - 06/2008
3	AlbuminsIBA 09/2021 - 03/2005
3	BilirubinIBA 09/2021 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2010
3	DNA (Deoxyribonucleic Acid)IBA 03/2011 - 01/2008
2	Carrier Proteins (Binding Protein)IBA 05/2019 - 11/2018
2	wisteria lectinIBA 05/2019 - 11/2018
2	Ribavirin (Virazole)FDA LinkGeneric 03/2014 - 09/2012
2	Prothrombin (Factor II)IBA 06/2013 - 08/2009
2	Serum AlbuminIBA 02/2013 - 03/2005
2	olmesartanIBA 11/2011 - 12/2007
2	Surface Antigens (Surface Antigen)IBA 03/2011 - 08/2010
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 08/2010 - 06/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2022
1	Rifaximin (L 105)FDA Link 01/2022
1	Phospholipases (Phospholipase)IBA 01/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	atezolizumabIBA 08/2021
1	Bevacizumab (Avastin)FDA Link 08/2021
1	Immune Checkpoint InhibitorsIBA 08/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	AntacidsIBA 11/2020
1	AcidsIBA 11/2020
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2020
1	Tyrosine Kinase InhibitorsIBA 09/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	DiureticsIBA 01/2020
1	Furosemide (Lasix)FDA LinkGeneric 01/2020
1	Tolvaptan FDA Link 01/2020
1	Epirubicin (Ellence)FDA LinkGeneric 04/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2019
1	Ethiodized Oil (Ethiodol)FDA Link 04/2019
1	asunaprevirIBA 04/2018
1	daclatasvirIBA 04/2018
1	miriplatinIBA 02/2018
1	thiamine triphosphorate (TTP)IBA 02/2018
1	gadolinium ethoxybenzyl DTPA FDA Link 10/2017
1	Cisplatin (Platino)FDA LinkGeneric 03/2015
1	Inosine TriphosphataseIBA 03/2014
1	Fetal Proteins (Fetoprotein)IBA 06/2013
1	Tumor Biomarkers (Tumor Markers)IBA 06/2013
1	Branched-Chain Amino AcidsIBA 02/2013
1	Rabeprazole (Aciphex)FDA Link 02/2012
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2011
1	ProcollagenIBA 11/2011
1	AngiotensinsIBA 11/2011
1	Collagen Type IV (Type IV Collagen)IBA 11/2011

Therapy/Procedure

20	Therapeutics 08/2022 - 03/2005
7	Radiofrequency Ablation 04/2019 - 03/2005
3	Ligation 11/2020 - 12/2007
3	Drug Therapy (Chemotherapy) 10/2019 - 08/2010
3	Radiotherapy 05/2014 - 01/2007
1	Splenectomy 07/2022
1	Drug Tapering 01/2020
1	Debridement 04/2019
1	Pancreaticoduodenectomy 04/2019
1	Aftercare (After-Treatment) 04/2018
1	Sclerotherapy 05/2016